Ptc Therapeutics (PTCT) Tax Provisions (2015 - 2026)

Ptc Therapeutics' Tax Provisions history runs 12 years deep, the most recent figure standing at $347000.0 for Q1 2026.

• In Q1 2026, Tax Provisions fell 99.45% year-over-year to $347000.0; the TTM figure through Mar 2026 stood at -$60.2 million (down 179.4% YoY), while the FY2025 annual figure was $2.7 million, down 85.95% from the prior year.
• Tax Provisions was $347000.0 for Q1 2026 at Ptc Therapeutics, up from -$15.4 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $63.3 million in Q1 2025 to a low of -$39.0 million in Q3 2025.
• Historically, Tax Provisions has averaged -$2.7 million across 5 years, with a median of $347000.0 in 2026.
• Biggest YoY gain for Tax Provisions was 972.06% in 2022; the steepest drop was 49602.78% in 2022.
• A 5-year view of Tax Provisions shows it stood at $11.2 million in 2022, then sank by 111.19% to -$1.3 million in 2023, then slumped by 660.13% to -$9.6 million in 2024, then plunged by 60.55% to -$15.4 million in 2025, then surged by 102.26% to $347000.0 in 2026.
• The last three Tax Provisions figures came in at $347000.0 (Q1 2026), -$15.4 million (Q4 2025), and -$39.0 million (Q3 2025), per Business Quant data.